G01N 33/5017
For testing neoplastic activity
Official title: {for testing neoplastic activity}
G01N33/5017 (For testing neoplastic activity) appears on 307 US grants and 404 published applications in this corpus.
Search patents in G01N- Granted patents
- 307
- Published applications
- 404
- Assignees
- 269
- Inventors
- 903
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 18 | 0 |
| 1999 | 15 | 0 |
| 2000 | 12 | 0 |
| 2001 | 20 | 2 |
| 2002 | 16 | 16 |
| 2003 | 9 | 35 |
| 2004 | 8 | 25 |
| 2005 | 11 | 20 |
| 2006 | 11 | 28 |
| 2007 | 7 | 24 |
| 2008 | 14 | 21 |
| 2009 | 8 | 18 |
| 2010 | 5 | 16 |
| 2011 | 5 | 15 |
| 2012 | 12 | 11 |
| 2013 | 4 | 10 |
| 2014 | 7 | 32 |
| 2015 | 9 | 11 |
| 2016 | 6 | 12 |
| 2017 | 6 | 12 |
| 2018 | 15 | 13 |
| 2019 | 6 | 18 |
| 2020 | 4 | 7 |
| 2021 | 2 | 12 |
| 2022 | 8 | 12 |
| 2023 | 6 | 9 |
| 2024 | 7 | 11 |
| 2025 | 5 | 9 |
| 2026 | 6 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- IFNβ as a pharmacodynamic marker in VSV-IFNβ-NIS oncolytic therapy6 Oct 2026US 12,754,182 B2Mayo Foundation for Medical Education and Research
- Uses of labeled HSP90 inhibitors5 May 2026US 12,616,759 B2Sloan-Kettering Institute for Cancer Research
- Long non-coding RNA LETN serving as tumor marker and therapeutic target point28 Apr 2026US 12,612,665 B2Tsinghua University
- Methods for performing miniaturized dynamic assays using microfluidics and related systems31 Mar 2026US 12,590,952 B2Biobridge Global
- Methods for screening cereblon modifying compounds31 Mar 2026US 12,590,953 B2Celgene Corporation
- Prophylactic or therapeutic against exacerbation or recurrence of cancer, and screening method therefor17 Sep 2026US 2026/0276624 A1
- Methods for performing miniaturized dynamic assays using microfluidics and related systems9 Jul 2026US 2026/0194515 A1Biobridge Global
- Apparatus for observation of biological activity in a sample and a method for quantifying cancer intravasation events in a biological sample18 Jun 2026US 2026/0168986 A1Center for Neuromusculoskeletal Restorative Medicine Limited
- Method and animal model for inducing bcc tumors5 Feb 2026US 2026/0033466 A1Feldan Bio Inc.
- Biomarker for diagnosis of gastric cancer29 Jan 2026US 2026/0028679 A1Samsung Life Public Welfare Foundation
Most cited
By later US patents
- Transgenic non-human mammals531US 4,736,866 APresident and Fellows of Harvard College · 1988
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Reconstituted basement membrane complex with biological activity212US 4,829,000 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1989
- Neural transplantation using proliferated multipotent neural stem cells and their progeny176US 6,497,872 B1Neurospheres Holdings Ltd. · 2002